As the advanced therapies landscape continues to evolve, with the ever increasing number of new cell and gene therapy products being evaluated along with anticipated regulatory approvals on the rise, how can we enhance delivery of these transformational treatments to patients? Cynthia will discuss various levers, each critical to success, including process, technology, people, systems and infrastructure.
Board Member | Advisor & Executive Consulting Partner,
Former Spark Therapeutics CTO|Former Ipsen Bioscience Biomeasure President & CEO
You must be logged in and own this session in order to